Drug Profile
Baclofen intravenous - Allaysis
Alternative Names: ALL-1401Latest Information Update: 05 Sep 2023
Price :
$50
*
At a glance
- Originator Allaysis
- Class Aminobutyric acids; Antispastics; Muscle relaxants; Small molecules
- Mechanism of Action GABA B receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Muscle spasticity
Most Recent Events
- 05 Sep 2023 Baclofen intravenous is still in preclinical phase for Muscle-spasticity in USA (IV, Infusion) (Allaysis pipeline; September 2023)
- 28 Mar 2020 No recent reports of development identified for preclinical development in Muscle-spasticity in USA (IV, Infusion)
- 19 May 2016 Chemical structure information added